Just - Evotec Biologics
Kevin Ingham is a highly experienced professional in the biologics industry, currently serving as the Vice President and Site Leader at Just - Evotec Biologics. With a background in engineering and geophysics, he has held various leadership roles at companies like AGC Biologics, Roche, and Genentech, overseeing operations, manufacturing, and technology support in drug product and biologics manufacturing. His expertise lies in continuous bioprocessing, GMP implementation, and strategic planning to expand global access to biotherapeutics.
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com